EPIDEMIOLOGY OF NONCOMMUNICABLE DISEASES AND CARDIOMETABOLIC RISK FACTORS IN CENTRAL ASIA: A COMPARATIVE ANALYSIS WITH A FOCUS ON UZBEKISTAN

Authors

Keywords:

noncommunicable diseases; epidemiology; Central Asia; Uzbekistan; arterial hypertension; cardiometabolic risk; population surveillance; disease prevention; health systems.

Abstract

Background. Noncommunicable diseases (NCDs) account for a large share of premature mortality, and cardiometabolic risk-factor surveillance is particularly relevant for health systems in Central Asia. Objective. To compare the latest harmonized estimates of hypertension prevalence, diagnosis, treatment, and control in five Central Asian countries and contextualize the epidemiological implications for Uzbekistan. Materials and Methods. A descriptive secondary analysis was conducted using the WHO 2025 hypertension country profiles (2024 model-based estimates), WHO NCD surveillance materials, Global Burden of Disease publications, and peer-reviewed regional policy studies available by 14 November 2026. Published aggregate figures were tabulated without access to individual records, inferential reanalysis, or meta-analysis. Results. Estimated hypertension prevalence among adults aged 30–79 years ranged from 37% in Turkmenistan to 47% in Uzbekistan; corresponding control among people with hypertension ranged from 8% in Tajikistan to 34% in Kazakhstan. Uzbekistan had an estimated 8.0 million adults with hypertension, of whom 53% were diagnosed, 43% treated, and 18% controlled. In the WHO profiles, estimated obesity prevalence was 29% (2022), physical inactivity 32% (2022), and mean salt intake 9 g/day (2021). A reconstructed care-state distribution indicated that 47% of affected adults were undiagnosed, 10% diagnosed but untreated, and 25% treated but uncontrolled, using rounded WHO estimates. Conclusion. Central Asia exhibits substantial heterogeneity in detection and treatment success despite a shared cardiometabolic burden. Epidemiological priorities for Uzbekistan include updated population-based surveys, equitable screening, standardized primary-care treatment pathways, and measurable risk-reduction policies. Findings are descriptive and do not establish the effectiveness of any proposed intervention [1–4,12,15].

 

References

1. World Health Organization. Noncommunicable diseases. WHO fact sheet. Updated 25 September 2025. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

2. World Health Organization. Global report on hypertension 2025: high stakes—turning evidence into action. Geneva: WHO; 2025. ISBN: 9789240115569. https://www.who.int/publications/i/item/9789240115569

3. World Health Organization. Explanatory notes for 2025 hypertension profiles. WHO; 2025. https://cdn.who.int/media/docs/default-source/country-profiles/hypertension/explanatory_notes_for_2025_hypertension_profiles.pdf

4. World Health Organization. Hypertension country profiles, 2025. Annex 1 of the Global Report on Hypertension 2025. Geneva: WHO; 2025. https://cdn.who.int/media/docs/default-source/country-profiles/hypertension/hypertension_country_profiles_2025.pdf

5. European Observatory on Health Systems and Policies. Health Systems in Action: Uzbekistan. Copenhagen: WHO Regional Office for Europe; 2024. ISBN: 9789289059824. https://eurohealthobservatory.who.int/publications/i/health-systems-in-action-uzbekistan-2024

6. World Health Organization Regional Office for Europe. Prevalence of Risk Factors for Noncommunicable Diseases in the Republic of Uzbekistan, 2019. Copenhagen: WHO; 2022. WHO/EURO:2022-6795-46561-67569. https://www.who.int/europe/publications/i/item/WHO-EURO-2022-6795-46561-67569

7. World Health Organization. Noncommunicable diseases progress monitor 2025. Geneva: WHO; 2025. ISBN: 9789240105775. https://www.who.int/publications/i/item/9789240105775

8. World Health Organization. Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases. 2nd ed. Geneva: WHO; 2024. ISBN: 9789240091078. https://www.who.int/publications/i/item/9789240091078

9. World Health Organization. HEARTS: Technical package for cardiovascular disease management in primary health care. Risk-based CVD management. Geneva: WHO; 2020. ISBN: 9789240001367. https://www.who.int/publications/i/item/hearts-technical-package

10. World Health Organization. Global status report on physical activity 2022. Geneva: WHO; 2022. ISBN: 9789240059153. https://www.who.int/publications/i/item/9789240059153

11. World Health Organization. Uzbekistan—STEPS 2019: survey catalog and metadata. WHO NCD Microdata Repository; catalog entry updated 2026. https://extranet.who.int/ncdsmicrodata/index.php/catalog/980

12. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1.

13. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162–2203. doi:10.1016/S0140-6736(24)00933-4.

14. Li J, Pandian V, Davidson PM, Song Y, Chen N, Fong DYT. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Int J Surg. 2025;111(3):2385–2397. doi:10.1097/JS9.0000000000002260.

15. Zhang Y, Deng Q, Hu P, Zeng Q, Li B, Liu J. Burden and risk factors of cardiovascular diseases in Asia, 1990–2021: an analysis for GBD 2021. JACC Asia. 2026;6(8 Pt 2):1750–1761. doi:10.1016/j.jacasi.2025.08.024.

16. Dumcheva A, Laatikainen T, Rakovac I, Nevalainen J, Nuorti JP. Assessing the progress in implementing population-based policies to reduce the burden of noncommunicable diseases in Eastern Europe and Central Asia, 2010–2024. Health Policy Plan. 2026;41(6):942–954. doi:10.1093/heapol/czag055.

17. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–1050. doi:10.1016/S0140-6736(23)02750-2.

18. NCD Risk Factor Collaboration (NCD-RisC). Obesity rise plateaus in developed nations and accelerates in developing nations. Nature. 2026;653:510–518. doi:10.1038/s41586-026-10383-0.

Published

2026-11-07